Ottawa is weighing a magic mushroom bill.
We dive into some data.
Hint: it has to do with data sovereignty.
“Quickly became the only newsletter I open every morning. I like that I know what’s going on, but don’t feel terrible after I finish reading.” -Amy, reader since 2022
Lulu is taking some heat in China.
GoFundMe's are paying Canadians' bills.
The feds take another crack at the First Nations water crisis.
Good luck getting a table without a $900 Amex.
We asked and found out.
Why is the DRC’s Ebola outbreak so alarming?
And can film play a role in Canadian sovereignty?
What, if anything, can we learn from the complicated track record of Milei’s radical economic experiment?
Another major Canadian IPO could be on the horizon.
Mythos is causing some more drama.
What's old is new again.
Live on the ground at the Eurasia Group’s U.S.-Canada Summit.
Quick Q&As with Canadians doing interesting things.
A Q&A with the restaurateur behind some of Toronto's top dining rooms.
A Q&A with the Canada Soccer CEO.
Life sciences investing, innovation in cancer treatment, and opportunities in Canada's biotech sector.